| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZyVersa Therapeutics, Inc. | Chief Commercial Officer | Stock Options | 48,100 | 11 Jul 2025 | Direct | ||
| ZyVersa Therapeutics, Inc. | Chief Commercial Officer | Stock Options | 572 | 24 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | 11 Jul 2025 | 1 | $0 | 4 | Chief Commercial Officer | 16 Jul 2025, 12:55 |
| ZVSA | ZyVersa Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 18 Jul 2024, 21:35 |
| ZVSA | ZyVersa Therapeutics, Inc. | 12 Dec 2022 | 5 | $0 | 4 | Chief Commercial Officer | 14 Dec 2022, 18:27 |
| ZVSA | ZyVersa Therapeutics, Inc. | 12 Dec 2022 | 0 | $0 | 3 | Chief Commercial Officer | 13 Dec 2022, 09:36 |